Foodconsumer.org

 
USCards.com Bookmark Us
All Food, Diet and Health News 
 
 Misc. News
 Must-Read News
 Letter to Editor
 Featured Products
 Recalls & Alerts
 Consumer Affair
 Non-food Things
 Health Tips
 Interesting Sites
 
 Diet & Health
 Heart & Blood
 Cancer
 Body Weight
 Children & Women
 General Health
 Nutrition
 
 Food & Health
 Food Chemicals
 Biological Agents
 Cooking & Packing
 Technologies
 Agri. & Environ.
 Laws & Politics
 
 General Health
 Drug News
 Diseases
 Mental Health
 Infectious Disease
 Environment
 Lifestyle
 Government
 Other News
 
 Food Consumer
 FC News & Others
Search





Search Foodconsumer & Others


Add to Google
Add to My Yahoo
Newsfeed

foodconsumer.org news feed
Su bmit news[release]



More than 100 credit cards available at uscards.com from uscards.com, you can pick more than 100 credit cards


Misc. News : Non-food Things Last Updated: Apr 20, 2011 - 9:38:09 AM


FDA: Tell patients about risks of ADHD drugs
By Ben Wasserman - foodconsumer.org
Feb 22, 2007 - 9:57:24 AM

E.mail t.his a.rticle
 P.rinter f.riendly p.age
Get n.ewsletter
 
   
The Food and Drug Administration on Wednesday announced its decision to require manufacturers of medications approved to treat Attention Deficit Hyperactivity Disorder (ADHD) to inform patients of possible adverse effects of using all types of ADHD drugs and approaches that can be used to minimize the risks.

The drugs of concern include Adderall, Adderall XR, Concerta, Daytrana, Desoxyn, Dexedrine, Focalin, Focalin XR, Metadate CD, Methylin, Methylin, Ritalin, Ritalin SR, Ritalin LA, and Strattera, which are manufactured by a host of drug companies including Eli Lilly and Co, Novartis AG, Johnson & Johnson, and Shire plc.

The ADHD drug makers have been told to produce Patient Medication Guides to alert patients of possible risks of adverse cardiovascular and psychiatric symptoms and the precautions they may take to minimize these risks.

Patient Medication Guides are given to the patient, families and caregivers when an ADHD medicine is dispersed. The information is intended to prevent serious adverse side effects and remind patients of the possible risks associated with the ADHD drugs.

Patients being treated with ADHD drugs are advised to read the information in the FDA-pre-approved guides before taking the medication and talk to their doctors if they have any questions or concerns, the FDA says in a statement.

"Medicines approved for the treatment of ADHD have real benefits for many patients but they may have serious risks as well," said Steven Galson, M.D., Director, Center for Drug Evaluation and Research (CDER).

"In our ongoing commitment to strengthen drug safety, FDA is working closely with manufacturers of all ADHD medicines to include important information in the product labeling and in developing new Patient Medication Guides to better inform doctors and patients about these concerns."

ADHD, which is characterized by three major symptoms, inattention, hyperactivity and impulsivity, affects 3 to 7 per cent of schoolchildren and 4 percent of adults.   An estimated 2 million people in the U.S. suffer from this condition.

"People with ADHD may have difficulty in school, troubled relationships with family and peers, and low self-esteem control," the FDA says.

The FDA's decision to provide patients with the information on ADHD drugs came after the agency reviewed reports of cases in which patients experienced adverse effects and concluded that patients who take ADHD drugs may be at slightly increased risk of cardiovascular adverse events or psychiatric adverse events.

According to the FDA, there have been reports of sudden death in patients on an ADHD drug with underlying serious heart problems or defects and reports of stroke and heart attack in adults with certain risk factors.

Taking ADHD medicines also increases risk by 1 per 1000 for drug-related psychiatric events such as hearing voices, becoming suspicious for no reason, or becoming manic, even in patients who did not have previous psychiatric problems.

The FDA requires the drug makers to produce a patient medication guide for each ADHD medicine to give patients information on reported adverse events, who should not take the drug, common side-effects, drug ingredients,   and some basics about the medication.

Taking Adderall as an example, reported heart related adverse events associated with this ADHD drug include sudden death in patients who have heart problems or defects, stroke and heart attack in adults, increased blood pressure and heart rate.

Again taking Adderall as an example, reported mental or psychiatric problems associated with this ADHD medicine include new or worse behavior and thought problems, bipolar illness, aggressive behavior or hostility in all patients.   In children and teenagers, the problems also include new psychotic symptoms including hearing voices, believing things that are not true, and suspicious or new manic symptoms.

Taking Adderall may also slow growth in children and cause seizure, mainly in patients with a history of seizure, eyesight changes or blurred vision.   Common side effects with this ADHD medicine include headache, decreased appetite, stomach ache, nervousness, trouble sleeping dizziness, according to the patient medication guide draft indicated for the medicine.

Other ADHD may have the same or similar adverse effects as Adderall.   For the detailed guides for each ADHD drug, visit http://www.fda.gov/cder/drug/infopage/ADHD/default.htm

The FDA recommends that patients who intend to use ADHD drugs talk to their doctors or healthcare professionals to develop a treatment plan that includes a careful health history and evaluation of current status, particularly for cardiovascular and psychiatric problems.

In May 2006, the FDA already directed manufacturers of these ADHD products to revise product labeling to remind doctors of adverse cardiovascular and psychiatric events.

Critics complain that the FDA acts too slow.  In September 2006, Health Canada already warned patients of adverse cardiovascular events and psychiatric events associated with all types of ADHD drugs.
 

For more information, visit the following

Adverse effects of ADHD drugs ,
List of Patinet Medication Guide Drafts
*  ADHD drugs and Cardiovascular risk  
*
  General information on ADHD








© 2004-2008 by foodconsumer.org unless otherwise specified

Top of Page




Google
 
Web foodconsumer.org

Search Consumer-friendly Health Sites












We have moved to Food Consumer . Org



disclaimer | advertising | jobs | privacy | about us | newsletter | Submit news/articles
link partners: | Buy Viagra | MarketAmerica.com |
Buy a home | Auto Insurance | Mortgage refinancing | DaytonaCPA.com | Take Your Blog to a Higher Level
© Copyright 2004 - 2008 foodconsumer.org All rights reserved

Disclaimer: What's published on this website should be considered opinions of respective writers only and foodconsumer.org which has no political agenda nor commercial ambition may or may not endorse any opinion of any writer. No accuracy is guaranteed although writers are doing their best to provide accurate information only. The information on this website should not be construed as medical advice and should not be used to replace professional services provided by qualified or licensed health care workers. The site serves only as a platform for writers and readers to share knowledge, experience, and information from the scientific community, organizations, government agencies and individuals. Foodconsumer.org encourages readers who have had medical conditions to consult with licensed health care providers - conventional and or alternative medical practitioners.